Harvard Bioscience Inc. (NASDAQ:HBIO) shares saw strong trading volume on Thursday . 119,286 shares were traded during mid-day trading, an increase of 42% from the previous session’s volume of 84,016 shares.The stock last traded at $2.54 and had previously closed at $2.53.

Separately, Zacks Investment Research lowered Harvard Bioscience from a “hold” rating to a “sell” rating in a report on Thursday, May 5th.

The firm’s market cap is $87.84 million. The firm has a 50-day moving average price of $2.85 and a 200 day moving average price of $2.99.

Harvard Bioscience (NASDAQ:HBIO) last issued its quarterly earnings data on Thursday, July 28th. The company reported $0.03 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.03. The business had revenue of $26.10 million for the quarter, compared to analyst estimates of $26.60 million. On average, equities research analysts expect that Harvard Bioscience Inc. will post $0.16 EPS for the current fiscal year.

Harvard Bioscience, Inc is a developer, manufacturer and marketer of a range of specialized products, apparatus and scientific instruments. The Company’s products are used to advance life science research at pharmaceutical and biotechnology companies, universities and government laboratories across the world.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.